Literature DB >> 19998747

A legal duty to disclose individual research findings to research subjects?

Matthew P Gordon.   

Abstract

Research that utilizes human subjects is a large and growing enterprise. Tens of millions of individuals have already participated as subjects in one or more research protocols, and millions more participate each year. Government and industry combined spend billions annually to support as many as 20,000 research studies, many of which are individually large and complex enterprises in their own right.These numbers are, if anything, likely to increase even further. Besides the growth in research, two other trends are apparent. First, research-related litigation is on the rise and appears likely to become even more widespread. Sparked at least in part by recent widely publicized instances of harm befalling research subjects, plaintiffs' attorneys are suing both more often and more creatively. Related to this is the second trend: public trust in research is declining and, as a result, at least some types of research are struggling to find adequate numbers of human subjects.As a result of these trends, exposure to potential liability and public perception are both increasingly important. Concomitant with all of this research is the discovery and generation of tremendous quantities of data specific to individual subjects, including--but not limited to--genetic information. Much of this data is irrelevant to subjects' interests because it lacks predictive value, has uncertain meaning, or is otherwise uninformative. Some, however, is different--some of the personal data learned during the course of research with human subjects bears directly on individuals' health. Despite the fact that much individual data has already been generated and that both the quantity and the quality of data generated seem likely to increase, there is a lack of clear guidance for researchers regarding whether and when such information should be divulged to the subjects on whom it bears.In this environment, the potential exists for litigation alleging that a researcher was negligent for failure to disclose to a subject an individual research finding of medical significance. Such litigation would raise a heretofore-unanswered question: should a researcher have a legal duty to disclose medically significant individual research findings to a subject?

Entities:  

Mesh:

Year:  2009        PMID: 19998747

Source DB:  PubMed          Journal:  Food Drug Law J        ISSN: 1064-590X            Impact factor:   0.619


  7 in total

1.  Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomic Research.

Authors:  Elizabeth R Pike; Karen H Rothenberg; Benjamin E Berkman
Journal:  Georgetown Law J       Date:  2014

2.  Return of results: ethical and legal distinctions between research and clinical care.

Authors:  Wylie Burke; Barbara J Evans; Gail P Jarvik
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-03-10       Impact factor: 3.908

3.  Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions.

Authors:  Fook Yee Cheung; Lauren Clatch; Susan M Wolf; Ellen Wright Clayton; Frances Lawrenz
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

4.  A framework for analyzing the ethics of disclosing genetic research findings.

Authors:  Lisa Eckstein; Jeremy R Garrett; Benjamin E Berkman
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

5.  Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?

Authors:  Kristen Underhill
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

Review 6.  The Legal Implications of Report Back in Household Exposure Studies.

Authors:  Shaun A Goho
Journal:  Environ Health Perspect       Date:  2016-05-06       Impact factor: 9.031

7.  Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.

Authors:  Barbara J Evans
Journal:  Genet Med       Date:  2013-09-12       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.